You have 9 free searches left this month | for more free features.

18F-fluoroethyl-tyrosine

Showing 1 - 25 of 2,804

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Intracranial Tumor, Low Grade Glioma, Recurrent Glioblastoma Trial in San Francisco (F-18 Fluoroethyltyrosine (FET), Positron

Recruiting
  • Intracranial Neoplasm
  • +4 more
  • F-18 Fluoroethyltyrosine (FET)
  • Positron Emission Tomography (PET)
  • San Francisco, California
    University of California, San Francisco
Nov 7, 2022

High Grade Glioma Trial in Birmingham (O-(2-[18F]Fluoroethyl)-L-tyrosine, [18F]-FET with PET/MRI)

Not yet recruiting
  • High Grade Glioma
  • O-(2-[18F]Fluoroethyl)-L-tyrosine, [18F]-FET with PET/MRI
  • Birmingham, Alabama
    UAB
Nov 21, 2022

Patients With Suspected or Diagnosed CNS Lymphoma Trial in Seoul ([18F]FET)

Recruiting
  • Patients With Suspected or Diagnosed Central Nervous System Lymphoma
  • Seoul, Songpa-Gu, Korea, Republic of
    Asan Medical Center
Oct 7, 2021

Glioma, High Grade Glioma, Glioma, Malignant Trial in Philadelphia (18F-Fluciclovine PET-MRI)

Recruiting
  • Glioma
  • +4 more
  • 18F-Fluciclovine PET-MRI
  • Philadelphia, Pennsylvania
    Children's Hospital of Philadelphia
Dec 22, 2022

Glioma, Low-grade Glioma, Low Grade Glioma of Brain Trial in Philadelphia (18F-Fluciclovine)

Not yet recruiting
  • Glioma
  • +4 more
  • Philadelphia, Pennsylvania
    Children's Hospital of Philadelphia
Oct 3, 2022

Primary Aldosteronism Trial in Calgary ([18-F]CETO)

Not yet recruiting
  • Primary Aldosteronism
  • [18-F]CETO
  • Calgary, Alberta, Canada
    University of Calgary
Jul 22, 2022

Comparaison Between MRI Alone or Combined With Positron Emission

Recruiting
  • Brain Metastases, Adult
    • Sherbrooke, Quebec, Canada
      CIUSSS de l'Estrie-CHUS
    Oct 15, 2021

    18F-Fluoro-Ethyl-Tyrosine Positron Emission Tomography and

    Completed
    • Positron Emission Tomography
    • Glioma
      • Brest, France
        CHRU de Brest
      Jan 14, 2020

      Brain Metastases: Value ofLongitudinal Multimodal Approach

      Recruiting
      • Brain Metastases, Adult
        • Brest, France
          Chu Brest
        Sep 6, 2023

        Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial in Worldwide (procedure, other, drug)

        Recruiting
        • Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
        • Biospecimen Collection
        • +4 more
        • Birmingham, Alabama
        • +170 more
        Jan 30, 2023

        Advanced Pancreatic Adenocarcinoma, Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma Trial in Boston (Zentalis, Gemzar)

        Not yet recruiting
        • Advanced Pancreatic Adenocarcinoma
        • +2 more
        • Boston, Massachusetts
        • +1 more
        Aug 23, 2023

        Atrial Fibrillation, Supraventricular Arrhythmia, Ventricular Arrhythmias and Cardiac Arrest Trial in New Hyde Park (Medtronic

        Recruiting
        • Atrial Fibrillation
        • +4 more
        • Medtronic LINQ-2 Insertable Cardiac Monitor (ILR)
        • New Hyde Park, New York
          Northwell (Northshore University/Long Island Jewish Hospitals)
        Dec 1, 2022

        Alzheimer Trial in Paris (Placebo, Masitinib (4.5), Standard of care)

        Not yet recruiting
        • Alzheimer Disease
        • Placebo
        • +2 more
        • Paris, France
          Institut de la mémoire et Maladie d'Alzheimer, Hôpitaux Universi
        Sep 29, 2022

        Eosinophilic Myeloid Tumor, Hypereosinophilic Syndrome Trial run by the National Institute of Allergy and Infectious Diseases

        Recruiting
        • Eosinophilic Myeloid Neoplasm
        • Hypereosinophilic Syndrome
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Jan 25, 2023

        [18F]Florbetazine for Beta Amyloid PET Imaging in Alzheimer's

        Recruiting
        • Alzheimer's Disease
        • Beijing, China
          Department of Nuclear Medicine, Peking Union Medical College Hop
        Nov 19, 2023

        Lobular Breast Carcinoma Trial in Monaco (68Ga-FAPI-46 PET scan)

        Not yet recruiting
        • Lobular Breast Carcinoma
        • 68Ga-FAPI-46 PET scan
        • Monaco, Monaco
          Centre Hospitalier Princesse Grace
        Jun 27, 2023

        EGF-R Positive NSCLC, Non Small Cell Lung Cancer, EGFR Exon 19 Deletion Trial in Bogotá (Stereotactic Body Radiation Therapy

        Not yet recruiting
        • EGF-R Positive Non-Small Cell Lung Cancer
        • +4 more
        • Stereotactic Body Radiation Therapy SBRT
        • Bogotá, Colombia
          CTIC - Centro de Tratamiento e Investigación Sobre Cáncer Luis C
        Aug 16, 2023

        Breast Cancer Trial in Madison (drug, device, other)

        Not yet recruiting
        • Breast Cancer
        • Madison, Wisconsin
          UW Carbone Cancer Center
        Oct 11, 2023

        18F-LN1 PET/CT in Urothelial Carcinomas

        Recruiting
        • Urothelial Carcinoma
          • Chengdu, Sichuan, China
            Departments of Nuclear Medicine, Sichuan Provincial People's Hos
          Nov 2, 2023

          Advanced Prostate Cancer, Metastatic Prostate Cancer, Metastatic Prostate Neuroendocrine Carcinoma Trial in Boston

          Not yet recruiting
          • Advanced Prostate Cancer
          • +2 more
          • Boston, Massachusetts
          • +1 more
          Sep 25, 2023

          Tumors Trial in Chengdu

          Recruiting
          • Neoplasms
            • Chengdu, Sichuan, China
              Departments of Nuclear Medicine, Sichuan Provincial People's Hos
            Oct 16, 2023

            Diagnostic Agent Adverse Reaction, Radiation Exposure Trial in New Haven (18F-LY3950321, PET Scan)

            Recruiting
            • Diagnostic Agent Adverse Reaction
            • Radiation Exposure
            • New Haven, Connecticut
              Invicro, LLC
            Mar 20, 2023

            Breast Cancer Stage II Trial in Xi'an (Anlotinib)

            Recruiting
            • Breast Cancer Stage II
            • Xi'an, Shannxi Province, China
              Xijing Hospital Affiliated to Air Force Military Medical Univers
            Sep 25, 2022

            Clear Cell Sarcoma of Soft Tissue Trial in Wuhan (18F-PFPN)

            Recruiting
            • Clear Cell Sarcoma of Soft Tissue
            • Wuhan, Hubei, China
              China, Hubei Province
            Jul 19, 2023